Trader consensus implies a 67% probability that the CDC will issue a Level 3 Travel Health Notice—recommending travelers avoid nonessential travel—by December 31, driven by multiple ongoing Level 2 alerts for outbreaks like meningococcal disease in the Democratic Republic of the Congo (issued March 24, 2026), clade II mpox in Ghana and Liberia (January 26, 2026), and yellow fever in Venezuela (March 16, 2026), per current CDC surveillance data. Recent catalysts include the agency's Emergency Operations Center activation at its lowest Level 3 for a hantavirus outbreak on May 8 and warnings of rising measles cases amid U.S. kindergarten vaccination rates dropping to 92.5%. Escalation risks persist with global poliovirus circulation and chikungunya surges, though forecasts carry uncertainty pending new case reports and WHO assessments.
Resumo experimental gerado por IA com dados do Polymarket. Isto não é aconselhamento de trading e não tem qualquer papel na resolução deste mercado. · AtualizadoCDC emite aviso de Nível 3 até 31 de dezembro?
CDC emite aviso de Nível 3 até 31 de dezembro?
Sim
$117,028 Vol.
$117,028 Vol.
Sim
$117,028 Vol.
$117,028 Vol.
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Mercado Aberto: Jan 19, 2026, 3:15 PM ET
Resolver
0x65070BE91...A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Resolver
0x65070BE91...Trader consensus implies a 67% probability that the CDC will issue a Level 3 Travel Health Notice—recommending travelers avoid nonessential travel—by December 31, driven by multiple ongoing Level 2 alerts for outbreaks like meningococcal disease in the Democratic Republic of the Congo (issued March 24, 2026), clade II mpox in Ghana and Liberia (January 26, 2026), and yellow fever in Venezuela (March 16, 2026), per current CDC surveillance data. Recent catalysts include the agency's Emergency Operations Center activation at its lowest Level 3 for a hantavirus outbreak on May 8 and warnings of rising measles cases amid U.S. kindergarten vaccination rates dropping to 92.5%. Escalation risks persist with global poliovirus circulation and chikungunya surges, though forecasts carry uncertainty pending new case reports and WHO assessments.
Resumo experimental gerado por IA com dados do Polymarket. Isto não é aconselhamento de trading e não tem qualquer papel na resolução deste mercado. · Atualizado
Cuidado com os links externos.
Cuidado com os links externos.
Frequently Asked Questions